Health Care & Life Sciences » Pharmaceuticals | Medicamen Biotech Ltd.

Medicamen Biotech Ltd. | Income Statement

Fiscal year is April-March. All values INR Millions.
2014
2015
2016
2017
2018
Sales/Revenue
732
778
673
825
1,115
Cost of Goods Sold (COGS) incl. D&A
619
668
565
651
788
Gross Income
113
110
108
174
327
SG&A Expense
68
72
61
60
183
EBIT
36
29
36
97
144
Non Operating Income/Expense
5
9
6
2
19
Interest Expense
40
39
36
36
24
Pretax Income
2
1
7
64
139
Income Tax
1
3
2
12
38
Consolidated Net Income
1
4
5
52
101
Net Income
1
4
5
52
101
Net Income After Extraordinaries
1
4
5
52
101
Net Income Available to Common
1
4
5
52
101
EPS (Basic)
0.11
0.49
0.48
4.95
9.03
Basic Shares Outstanding
9
9
10
10
-
EPS (Diluted)
0.11
0.49
0.48
4.95
-
Diluted Shares Outstanding
9
9
10
10
-
EBITDA
52
50
55
116
165
Other Operating Expense
9
9
10
17
-
Non-Operating Interest Income
1
2
1
1
-

About Medicamen Biotech

View Profile
Address
43, Nehru Place
New Delhi Delhi 110019
India
Employees -
Website http://www.medicamen.com
Updated 09/14/2018
Medicamen Biotech Ltd. engages in the manufacture and marketing of pharmaceutical formulations. Its products include tablets, capsules, liquid oral, dry syrup, ointment, lotions, and dental care. The company was founded by Bal Kishan Gupta on December 22, 1993 and is headquartered in New Delhi, India.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.